Artelo Biosciences Correlations

ARTL Stock

USD 3.41 -0.16 -4.48%

The current 90-days correlation between Artelo Biosciences and Protagenic Therapeutics is -0.25 (i.e., Strong inverse diversification).When its correlation with a broad index is high, most of the stock's return is explained by market movement.

Correlation Against Market - Artelo Biosciences

Very strong inverse diversification

Artelo Biosciences currently posts a -0.65 correlation with Dow Jones, indicating a Very strong inverse diversification relationship for the active sample. The overlap area shows the portion of risk diversified away by holding both instruments together.

Artelo Biosciences has a market cap of 3.35 M, current ratio of 42.28. Margin trends and liquidity ratios are among the first indicators to shift ahead of earnings revisions. Sector concentration and correlation with existing positions affect diversification impact. Broader economic conditions can influence Artelo Biosciences's company valuation - related indicators include signals in manufacturing.

For more information on Artelo Stock please use our How to Invest in Artelo Biosciences overview. It covers the key aspects of trading Artelo Stock.

Moving Against Artelo Stock

0.56	BVF	Bausch Health Companies Earnings Call Today	Pair Corr
0.55	FUM	Futura Medical	Pair Corr
0.53	EXL	Elixinol Wellness	Pair Corr
0.46	JAGX	Jaguar Animal Health	Pair Corr
0.43	MIST	Milestone Pharmaceuticals	Pair Corr
0.32	9TH0	EPSILON HEALTHCARE LTD	Pair Corr
0.32	RDHL	Redhill Biopharma	Pair Corr
0.31	EPN	Epsilon Healthcare	Pair Corr
0.65	KDP	Keurig Dr Pepper Aggressive Push	Pair Corr
0.6	AKTX	Akari Therapeutics PLC	Pair Corr
0.56	O	Realty Income Earnings Call This Week	Pair Corr
0.51	RCIT	Reelcause	Pair Corr
0.46	SNES	SenesTech	Pair Corr
0.42	TVRD	Tvardi Therapeutics	Pair Corr
0.38	KO	Coca Cola Aggressive Push	Pair Corr
0.35	DE	Deere Company	Pair Corr

Related Correlations Analysis

	GTBP	PTIX	CARM	SLRX	PBM	REVB	LIPO	SPRC	SLXN	WINT
GTBP		-0.45	0.57	0.72	-0.21	0.89	0.57	0.47	0.8	-0.03	GTBP
PTIX	-0.45		-0.74	-0.52	0.47	-0.34	-0.55	0.11	-0.67	0.5	PTIX
CARM	0.57	-0.74		0.46	-0.85	0.37	0.65	-0.19	0.74	-0.61	CARM
SLRX	0.72	-0.52	0.46		-0.08	0.81	0.68	0.57	0.64	-0.03	SLRX
PBM	-0.21	0.47	-0.85	-0.08		0.02	-0.37	0.52	-0.39	0.73	PBM
REVB	0.89	-0.34	0.37	0.81	0.02		0.51	0.68	0.71	0.21	REVB
LIPO	0.57	-0.55	0.65	0.68	-0.37	0.51		0.34	0.82	-0.32	LIPO
SPRC	0.47	0.11	-0.19	0.57	0.52	0.68	0.34		0.34	0.56	SPRC
SLXN	0.8	-0.67	0.74	0.64	-0.39	0.71	0.82	0.34		-0.26	SLXN
WINT	-0.03	0.5	-0.61	-0.03	0.73	0.21	-0.32	0.56	-0.26		WINT
	GTBP	PTIX	CARM	SLRX	PBM	REVB	LIPO	SPRC	SLXN	WINT

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

REVB	+ 0.89	GTBP
SLXN	+ 0.82	LIPO
REVB	+ 0.81	SLRX
SLXN	+ 0.8	GTBP
SLXN	+ 0.74	CARM
WINT	+ 0.73	PBM

High negative correlations

PBM	- 0.85	CARM
CARM	- 0.74	PTIX
SLXN	- 0.67	PTIX
WINT	- 0.61	CARM
LIPO	- 0.55	PTIX
SLRX	- 0.52	PTIX

Risk-Adjusted Indicators

Evaluating Artelo Stock requires separating price momentum from underlying operating strength versus competitors. Risk-adjusted metrics help compare Artelo Biosciences' efficiency and downside exposure against peers on a like-for-like basis. These indicators are quantitative in nature and measure volatility and risk-adjusted expected returns across different positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
GTBP	3.95	-1.25	0.00	-5.68	0.00	0.00	7.25	-10.64	29.97
PTIX	8.78	1.60	0.13	0.96	9.12	-12.75	21.15	-16.18	60.30
CARM	12.84	1.71	0.06	-0.77	19.31	-25.26	17.95	-13.64	300.00
SLRX	6.68	-1.93	0.00	3.33	0.00	0.00	16.00	-16.92	61.05
PBM	7.83	1.51	0.21	0.77	6.20	-11.28	22.08	-11.11	119.84
REVB	3.52	-1.10	0.00	-0.80	0.00	0.00	5.36	-8.89	21.13
LIPO	20.06	3.48	0.11	2.01	19.28	-47.61	61.29	-48.57	248.33
SPRC	6.27	0.32	0.05	1.78	6.67	-8.60	22.86	-10.00	48.25
SLXN	4.37	-1.66	0.00	-0.54	0.00	0.00	8.70	-12.33	28.57
WINT	13.12	3.45	0.00	0.69	0.00	0.00	100.00	-50.00	150.00

Artelo Biosciences Corporate Management

Jason Baybutt	Senior Vice President of Finance	Profile
Andrew Yates	Senior VP & Chief Scientific Officer	Profile
Steven Reich	Chief Officer	Profile
Steven MD	Chief Medical Officer	Profile
Gregory MBA	CEO and President	Profile